Nuveen
PGEN icon

Nuveen’s Precigen PGEN Stock Holding History

Nuveen’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.01M Buy
702,834
+168,823
+32% +$730K ﹤0.01% 2214
2026
Q1 		$2.07M Buy
534,011
+5,052
+1% +$20.7K ﹤0.01% 2268
2025
Q4 		$2.21M Sell
528,959
-269,848
-34% -$1.04M ﹤0.01% 2253
2025
Q3 		$2.63M Buy
798,807
+303,280
+61% +$856K ﹤0.01% 2188
2025
Q2 		$704K Buy
495,527
+310,659
+168% +$441K ﹤0.01% 2766
2025
Q1 		$5.2M Sell
184,868
-350,115
-65% -$551K ﹤0.01% 1911
2024
Q4 		$599K Hold
534,983
– – ﹤0.01% 2920
2024
Q3 		$507K Hold
534,983
– – ﹤0.01% 3012
2024
Q2 		$845K Hold
534,983
– – ﹤0.01% 2801
2024
Q1 		$776K Hold
534,983
– – ﹤0.01% 2803
2023
Q4 		$717K Buy
534,983
+9,955
+2% +$11.7K ﹤0.01% 2877
2023
Q3 		$746K Sell
525,028
-57,456
-10% -$81.4K ﹤0.01% 2693
2023
Q2 		$670K Sell
582,484
-101,101
-15% -$119K ﹤0.01% 2834
2023
Q1 		$725K Buy
683,585
+137,667
+25% +$198K ﹤0.01% 2715
2022
Q4 		$830K Sell
545,918
-64,575
-11% -$111K ﹤0.01% 2755
2022
Q3 		$1.29M Sell
610,493
-39,474
-6% -$83.2K ﹤0.01% 2623
2022
Q2 		$871K Buy
649,967
+121,148
+23% +$180K ﹤0.01% 2849
2022
Q1 		$1.11M Sell
528,819
-182,600
-26% -$445K ﹤0.01% 2782
2021
Q4 		$2.48M Buy
711,419
+123,923
+21% +$533K ﹤0.01% 2470
2021
Q3 		$3.22M Sell
587,496
-6,493
-1% -$37.4K ﹤0.01% 2444
2021
Q2 		$3.87M Buy
593,989
+89,358
+18% +$624K ﹤0.01% 2373
2021
Q1 		$3.48M Sell
504,631
-7,317
-1% -$61.9K ﹤0.01% 2348
2020
Q4 		$5.22M Sell
511,948
-344
-0.1% -$2.23K ﹤0.01% 2050
2020
Q3 		$1.79M Sell
512,292
-45,206
-8% -$215K ﹤0.01% 2440
2020
Q2 		$2.78M Buy
557,498
+72,613
+15% +$247K ﹤0.01% 2195
2020
Q1 		$1.65M Buy
484,885
+179,006
+59% +$772K ﹤0.01% 2280
2019
Q4 		$1.68M Buy
305,879
+14,450
+5% +$81.3K ﹤0.01% 2497
2019
Q3 		$1.67M Sell
291,429
-20,921
-7% -$142K ﹤0.01% 2486
2019
Q2 		$2.39M Buy
+312,350
New +$1.68M ﹤0.01% 2348

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen's PGEN Position: Q2 2026 in Review

Nuveen increased its Precigen (PGEN) stake by 32% in Q2 2026, buying an estimated $730K and bringing the position to 702,834 shares worth $4.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2214.

Nuveen first reported a position in PGEN in Q2 2019 and has held it in 29 quarters since. The position peaked at $5.22M in Q4 2020. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Nuveen held 702,834 shares of Precigen worth $4.01M as of Q2 2026.
  • Nuveen bought 168,823 Precigen shares in Q2 2026, an estimated $730K.
  • Precigen made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2214 holding.
  • Nuveen first reported a position in Precigen in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Precigen position peaked at $5.22M in Q4 2020.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.